Thomas E. Kiraly - 16 Dec 2021 Form 4 Insider Report for HANGER, INC.

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
17 Dec 2021, 15:54:31 UTC
Prior SEC filing
17 Sep 2021
Next SEC filing
16 Feb 2022
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
Jessica Lochmann Allen, Attorney-in-Fact for Thomas E. Kiraly

Key filing fact

Thomas E. Kiraly filed Form 4 for HANGER, INC. on 17 Dec 2021.

Key facts

  • This page summarizes Thomas E. Kiraly's Form 4 filing for HANGER, INC..
  • 1 reported transaction and 1 derivative row are listed below.
  • Accepted by SEC: 17 Dec 2021, 15:54.

Change

  • Previous filing in this sequence was filed on 17 Sep 2021.
  • Current net transaction value: -$151,362.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

HNGR transaction

Common Stock

Sale

Transaction value
$151,362
Shares
-8,750
Change %
-3.5%
Price
$17.30
Shares after
242,075
Date
16 Dec 2021
Ownership
Direct
Footnotes
F1, F2, F3, F4, F5, F6

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

HNGR holding Derivative

Stock Options (right to buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
31,389
Date
16 Dec 2021
Ownership
Direct
Underlying class
Common Stock
Underlying amount
62,778
Exercise price
$12.77
Footnotes
F7
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 7 footnotes

Footnote F1

The sale by Mr. Kiraly was effected automatically upon the satisfaction of certain timing, trading price and other conditions under a trading plan designed to comply with Rule 10b5-1 of the Securities Exchange Act of 1934. Mr. Kiraly entered into this trading plan on December 4, 2020.

Footnote F2

These shares were sold at a range of sale prices from $17.00 to $17.72. The reporting person will provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

Footnote F3

Includes (i) unvested restricted shares totaling 17,435 shares of stock from an initial grant of 17,435 shares of restricted stock which begins to vest on March 8, 2022 (ii) unvested restricted shares totaling 13,094 shares of stock from an initial grant of 14,523 shares of restricted stock made on March 9, 2020 (iii) unvested restricted shares totaling 15,404 shares of stock from an initial grant of 17,085 shares of restricted stock made on March 9, 2020; (iv) unvested restricted shares and fully vested shares totaling 10,546 shares of stock from an initial grant of 16,185 shares of restricted stock made on March 8, 2019; [continued in next footnote]

Footnote F4

(v) unvested restricted shares and fully vested shares totaling 12,499 shares of stock from an initial grant of 19,181 shares of restricted stock made on March 8, 2019; (vi) unvested restricted shares and fully vested shares totaling 11,605 shares of stock from an initial grant of 18,622 shares of restricted stock made on March 9, 2018; (vii) unvested restricted shares and fully vested shares totaling 12,924 shares of stock from an initial grant of 26,250 shares of restricted stock, the remainder of which vested on March 8, 2021; (viii) unvested restricted shares and fully vested shares totaling 12,950 shares of stock from an initial grant of 23,408 shares of restricted stock made on March 8, 2018; (ix) fully vested shares totaling 16,887 shares of stock from an initial grant of 23,844 shares of restricted stock made on March 6, 2015; [continued in next footnote]

Footnote F5

(x) unvested restricted shares and fully vested shares totaling 12,308 shares of stock from an initial grant of 25,000 shares of restricted stock made on March 8, 2017; (xi) fully vested shares totaling 3,182 shares of stock from an initial grant of 5,000 shares of restricted stock made on October 11, 2016; (xii) unvested restricted shares and fully vested shares totaling 13,096 shares of stock from an initial grant of 25,000 shares of restricted stock April 29, 2016; (xiii) fully vested shares totaling 12,037 shares of stock from an initial grant of 15,896 shares of restricted stock made on March 6, 2015 and (xiv) fully vested shares totaling 35,064 shares of stock from an initial grant of 49,660 shares of restricted stock made on October 1, 2014.

Footnote F6

Except as otherwise noted, all remaining unvested restricted shares will continue to vest at a rate of 25% per year of the original grant amount on the anniversary date of the grant.

Footnote F7

Stock options were granted under the Company's Special Equity Plan and vest 1/3 on each of May 19, 2018, 2019 and 2020.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .